The antidepressant sertraline: A review of its uses in a range of psychiatric and medical conditions

Comprehensive Therapy

Volumn 29, Issue 1, 2003, Pages 47-53

  Khouzam, Hani Raoul ^a,b   Emes, Robert ^c   Gill, Tirath ^c   Raroque, Roy ^c  

^a Chem Dependency Treatment Program   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMISULPRIDE; ATENOLOL; BUPRENORPHINE; CIMETIDINE; CLONIDINE; DESIPRAMINE; DIAZEPAM; DIGOXIN; FLUOXETINE; LEVACETYLMETHADOL; METHADONE; MONOAMINE OXIDASE INHIBITOR; NALOXONE; NALTREXONE; NICOTINE; OPIATE; PHENAZONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TOLBUTAMIDE; TRYPTOPHAN;

AKATHISIA; ANXIETY DISORDER; ARTICLE; BORDERLINE STATE; CHRONIC FATIGUE SYNDROME; CONFUSION; CONVULSION; DEATH; DIARRHEA; DRUG DOSE REGIMEN; DRUG INDICATION; DYSTHYMIA; DYSTONIA; EATING DISORDER; EJACULATION DISORDER; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; HYPERPYREXIA; HYPOTENSION; INSOMNIA; MENTAL DISEASE; MOOD DISORDER; MYOCLONUS; NAUSEA; PHARMACODYNAMICS; PREMENSTRUAL DYSPHORIC DISORDER; PSYCHOSIS; PUERPERAL DEPRESSION; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; SOMATOFORM DISORDER; TACHYCARDIA; TREMOR; VERTIGO; WITHDRAWAL SYNDROME; XEROSTOMIA;

ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; EATING DISORDERS; FATIGUE SYNDROME, CHRONIC; HUMANS; SERTRALINE; SOMATOFORM DISORDERS; SUBSTANCE-RELATED DISORDERS;

EID: 0037351711     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: 10.1385/COMP:29:1:47     Document Type: Article

References (52)

1. Hirschfeld RMA. Sertraline in the treatment of anxiety disorders. Depression Anxiety. 2000;11:139-57.
2. Eriksson E. Serotonin re-uptake inhibitors for the treatment of premenstrual dysphoria. Int Clin Psychopharmacol. 1999; 14(Suppl 2):S27-S33.
3. Kim SW, Park SY, Hwang O. Up-regulation of tryptophan hydroxylase expression and serotonin synthesis by sertraline. Mol Pharmacol. 2002;61:778-85.
4. Ilic TV, Korchounov A, Ziemann U. Complex modulation of human motor cortex excitability by the specific serotonin reuptake inhibitor sertraline. Neurosu Lett. 2002;319:116-20.
5. Kane JM. Extending indications for long-term pharmacotherapy: Opportunities and challenges. Am J Psychiatry. 2002;159:1-2.
6. Masand PS, Gupta S. Selective serotonin-reuptake inhibitors: An update. Harvard Rev Psychiatry. 1999;7:69-84.
7. Preskorn SH. Clinical pharmacology of selective serotonin reuptake inhibitors. Caddo. Oklahoma: Professional Communications, 1996.
8. Ronfeld RA, Tremaine LM, Wilner KD. Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers. Clin Pharmacokinet. 1997;32(Suppl 1):22-30.
9. Kaplan HI, Sadock BJ, eds. Obsessive-compulsive disorder. In: Synopsis of Psychiatry. 8th Ed. Baltimore: Williams & Wilkins, 1998:609-17.
10. Sproule BA, Naranjo CA, Brenner KE, Hassan PC. Selective serotonin reuptake Inhibitors and CNS drug interactions. A critical review of the evidence. Clin Pharmacokinet. 1997;33: 454-71.
11. Corkeron MA. Serotonin syndrome - a potentially fatal complication of antidepressant therapy. Med J Aust. 1995;163: 481-2.
12. Bogetto F, Bellino S, Revello RB, Patria L. Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: A clinical investigation. CNS Drugs. 2002;16:273-83.
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. Washington DC, 1994.
14. Straton JB, Cronholm P. Are paroxetine, fluoxetine, and sertraline equally effective for depression? J Fam Pract. 2002; 51:285.
15. Van Moffaert M, Bartholome F, Cosyns P, DeNayer AR, Mertens C. A controlled comparison of sertraline and fluoxetine in acute and continuation treatment of major depression. Hum Psychopharmacol. 1995;10:393-405.
16. Bennie EM, Mullin JM, Martindale JJ. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression. J Clin Psychiatry. 1995;56:229-37.
17. Lapierre YD. Pharmacological therapy of dysthymia. Acta Psychiatr Scand. Suppl. 1994;383:42-8.
18. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York: Oxford University Press, 1990.
19. Rothschild AJ, Phillips KA. Selective serotonin reuptake inhibitors and delusional depression. Am J Psychiatry. 1999; 156:977-8.
20. Alpay FB, Turham NO. Intermittent versus continuous sertraline therapy in the treatment of premenstrual dysphoric disorders. Int J Fertil Womens Med. 2001;46:228-31.
21. Wisner KL, Perel JM, Findling RL. Antidepressant treatment during breast-feeding. Am J Psychiatry. 1996;153:1132-7.
22. Schmidt PJ, Rubinow DR. Menopause-related affective disorders: A justification for further study. Am J Psychiatry. 1991;48:844-52.
23. Schneider LS, Small GW, Clary CM. Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. Am J Geriatr Psychiatry. 2001;9:393-9.
24. Roth AJ, Scher HI. Sertraline relieves hot flashes secondary to medical castration as treatment of advanced prostrate cancer. Psychooncology. 1998;7:129-32.
25. Burns A, Russell E, Stratton-Powell H, Tyrell P, O'Neil P, Baldwin R. Sertraline in stroke-associated lability of mood. Int J Geriatr Psychiatry. 1999;14:681-5.
26. Krishnan KR. Depression as a contributing factor in cerebrovascular disease. Am Heart J. 2000;140(Suppl 4):70-6.
27. Beshay H, Pumariega AJ. Sertraline treatment of mood disorder associated with prednisone: A case report. J Child Adolesc Psychopharmacol. 1998;8:187-93.
28. Wald A. Irritable bowel syndrome. Current Treat Options Gastroenterol. 1999;2:13-9.
29. Hauser RA, Zesiewicz TA. Sertraline for the treatment of depression in Parkinson's disease. Mov Disord. 1997;12:756-9.
30. Pollack MH, Smoller JW. The longitudinal course and outcome of panic disorder. Psychiatr Clin North Am. 1995;18: 785-801.
31. Pollack MH, Rapaport MH, Clary CM, Mardekian J, Wolkow R. Sertraline treatment of panic disorder: Response in patients at risk for poor outcome. J Clin Psychiatry. 2000; 61:922-7.
32. Khouzam HR. Obsessive-compulsive disorder. What to do if you recognize baffling behavior. Postgrad Med, 1999;106: 133-41.
33. Khouzam HR. A simple mnemonic for the diagnostic criteria for post-traumatic stress disorder. West J Med. 2001;174:424.
34. Khouzam HR, Donnelly NJ. Posttraumatic stress disorder, safe, effective management in the primary care setting. Postgrad Med. 2001;110:60-78.
35. Keck PE Jr, McElroy SL. New uses for antidepressants: Social phobia. J Clin Psychiatry. 1997;58(Suppl 14):32-6. Discussion 37-8.
36. Rynn MA, Siqueland L, Rickels K. Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. Am J Psychiatry. 2001;158:2008-14.
37. Schatzberg AF. New indications for antidepressants. J Clin Psychiatry. 2000;61(Suppl 11):9-17.
38. Pettinati HM, Volpicelli JR, Luck G, Kranzler HR, Rukstalis MR, Cnaan A. Double-blind clinical trial of sertraline treatment for alcohol dependence. J Clin Psychopharmacol. 2001; 21:143-53.
39. Resnick RB, Galenter M, Resnick E, Pycha C. Buprenorphine treatment of heroin dependence (detoxification and maintenance) in a private practice setting. J Addict Dis. 2001;20:75-83.
40. Akoaka H, Aston-Jones G. Indirect serotenergic agonists attenuate neuronal opiate withdrawal. Neuroscience. 1993; 54:561-5.
41. Diwan A, Castine M, Pomerleau CS, Meador-Woodruff JH, Dalack GW. Differential prevalence of cigarette smoking in patients with schizophrenia vs mood disorders. Schizophrenia Res. 1998;33:113-8.
42. American Psychiatric Association. Practice guidelines for eating disorders. Am J Psychiatry. 1993;150:212-28.
43. Santonastaso P, Friederici S, Favaro A. Sertraline in the treatment of restricting anorexia nervosa: An open controlled trial. J Child Adolesc Psychopharmacol. 2001;11:143-50.
44. Robert JM, Lydiard RB. Sertraline in the treatment of bulimia nervosa. Am J Psychiatry. 1993;150:1753.
45. McElroy SL, Casuto LS, Nelson EB, et al. Placebo-controlled trial of sertraline in the treatment of binge eating disorder. Am J Psychiatry. 2000;157:1004-6.
46. Wadden TA, Bartlett SJ, Foster GD, et al. Sertraline and relapse prevention training following treatment by verylow-calorie diet: A controlled clinical trial. Obes Res. 1995;3: 549-57.
47. Khouzam HR, Field S. Somatization disorder: clinical presentation and treatment in primary care. Hosp Physician. 1999;35(4):20-4,45.
48. Maina G, Vitalucci A, Gandolfo S, Bogetto F. Comparative efficacy of SSRI's and amisulpride in burning mouth syndrome: A single-blind study. J Clin Psychiatry. 2002;63:38-43.
49. Hoss D, Segal S. Scalp dysesthesia. Arch Dermatol. 1998;134: 327-30.
50. Perkins RJ. SSRI antidepressants are effective for treating delusional hypochondriasis. Med J Aust. 1999;170:140-1.
51. Ansari A. The efficacy of newer antidepressants in the treatment of chronic pain: A review of current literature. Harvard Rev Psychiatry. 2000;7:257-77.
52. Khouzam HR. Chronic fatigue syndrome: Update on diagnosis and treatment. Consultant. 2000;40:1441-50.